In this report we have studied the mechanism by which Transforming Growth Factor beta (TGFb) inhibits growth of human myeloid leukemia cell lines. TGFb1 arrested cells in G1 phase and signi®cantly downregulated the expression of cyclin D2, cyclin D3, cdk4, cyclin A, and cdk2. The downregulation of the molecules resulted in approximately 50 ± 90% decrease of the molecule-dependent kinase activity, varying with each molecule. Although treatment of cells with TGFb1 upregulated accumulation of p27 kip1 in both nucleus and cytoplasm, the association of the p27 kip1 with cdk2, cyclin A, cyclin D2, cyclin D3, and cdk4 was markedly downregulated, suggesting that p27 kip1 is not responsible for the downregulation of the kinase activity. In contrast, TGFb1 upregulated cyclin E-associated p27 kip1 with no eect on the expression of cyclin E. p27 kip1 -immunodepletion upregulated cyclin E-dependent kinase activity by more than 10-fold in TGFb1-treated cells but not in proliferating cells; whereas immunodepletion of p27 kip1 from cdk2-immunoprecipitates markedly downregulated cdk2 kinase activity in the lysates extracted from both proliferating and TGFb-treated cells. Consistent with this observation, TGFb1 and p27 kip1 antisense cDNA had a synergistic or additive inhibitory eect on cdk2 but not cyclin E-dependent kinase activity. Our data suggest that (1) TGFb1-mediated growth inhibition is accomplished through multiple pathways and (2) p27
Introduction
The G1 cyclin-cdk complexes are assumed to modify critical proteins by phosphorylation, thereby promoting cell cycle progression toward DNA replication (Ko et al., 1992; Matsushime et al., 1994; Resnitzky et al., 1994) . Each cyclin can associate with one or more of the cdk family, of which at least cdk2, cdk4, and cdk6 kinase activities have been shown to operate in G1 phase (Bates et al., 1994; Ko et al., 1993; Eween et al., 1993; Matsushime et al., 1992 Matsushime et al., , 1994 Meyerson and Harlow, 1994; Pagano et al., 1993; Tsai et al., 1993) . Cyclins D1-and D2-associated cdk4 and/ or cdk6 kinase activities have been detected in mid G1, prior to the activation of any other known cdk (Matsushime et al., 1994; Meyerson and Harlow, 1994; Pagano et al., 1993) . The cyclin D3-associated cdk4/cdk6 and cyclin E-bound cdk2 exhibit kinase activities at the G1/S transition (Ko et al., 1992 (Ko et al., , 1993 Matsushime et al., 1994; Meyerson and Harlow, 1994) , followed by cyclin A, cdk2, cyclin A-cdc2, and cyclin B-cdc2 kinase at the late stages of the cell division cycle (Matsushime et al., 1994; Pagano et al., 1993) . The activity of G1 cyclin-cdk complexes is regulated, at least in part, by cdk inhibitors (ckis). One family (Ink4 proteins) of cdk inhibitors includes p16
INK4A (Hannon and Beach, 1994), p15 INK4B (Kamb et al., 1994) , p18 (Guan et al., 1994) and related proteins of 15 ± 20 kDa (Hirai et al., 1995) . The second family (Cip/Kip) of ckis includes p21 Cip1 (Harper et al., 1993) , p27 kip1 Toyoshima and Hunter, 1994 ) and p57 kip2 (Matsuoka et al., 1995) . p27 kip1 is one of the most widely distributed cdk inhibitors, being expressed both in proliferating as well as dierentiated cells (Porter et al., 1997) . The inhibitor has been shown to be able to bind to cyclin D-cdk4, cyclin D-cdk6, cyclin A-cdk2, and cyclin E-cdk2 complexes and inhibits their activities in vitro Toyoshima and Hunter, 1994) . In vivo, p27 kip1 regulates negatively cyclin E-cdk2 complex activity in cells that are exposed to TGFb, lovastatin, rapamycin, vitamin D3, and cell contact inhibition Nourse et al., 1994; Poon et al., 1995; Slingerland et al., 1994; Liu et al., 1996; Reynisdottir et al., 1995) . Studies of constitutive expression of cdk4 suggest that cyclin Dcdk4 may operate temporally upstream from cyclin Ecdk2, as part of the mechanism that is responsible for cyclin-cdk2 activation (Eween et al., 1993) . Since TGFb1 treatment of HaCaT cells resulted in a dramatic Oncogene (2001) 20, 6840 ± 6850 increase of p15 INK4B mRNA and protein associated with cdk4 and cdk6, it was hypothesized that the p15 INK4B   induced by TGFb1 would bind cdk4 or cdk6,  destabilizing the D cyclins and displacing p27 kip1 , which in turn would leave p27 kip1 free to bind to and saturate cyclin E-cdk2, rendering it inactive (Poon et al., 1995; Reynisdottir et al., 1995) .
In this study, we have demonstrated that (1) downregulation of multiple G1 cell cycle regulatory molecules is a dominant event in TGFb-mediated growth inhibition of human myeloid leukemia cells; and (2) p27 kip1 has an opposing eect on cdk2 and cyclin E, being an activator of cdk2 and an inhibitor of cyclin E in cell cycle control.
Results

Effect of TGFb1 on G1 cyclin and cdk protein levels
Our previous data have demonstrated that TGFb1 induces dephosphorylation of pRb and profoundly inhibits proliferation of human myeloid leukemia MV4-11 cells (Hu et al., 2000) . Since synthesis of Dtype cyclins and phosphorylation of pRb are at approximately the same time in G1, we asked whether TGFb1 aects the abundance of the D-type cyclins and their catalytic subunits, cdk4 and cdk6. Thus, the expression of D-type cyclins and cdks in cells treated with or without TGFb1 was examined by Western blotting. Proliferating MV4-11 cells not exposed to TGFb1 expressed cyclin D2, cyclin D3, cdk4, and cdk6 as a single band at approximately 33 ± 35 kDa, and addition of TGFb1 caused a considerable decrease of cyclin D3 and cdk4 proteins measured by ImageQuant, as described under`Materials and methods'. The inhibition of cyclin D3, and cdk4 started at 6 h, with 90% reduction being observed by 24 h (P50.01) and maintained up to 48 h. In addition, TGFb1 also suppressed cyclin D2 to a lesser extent, with *80% (P50.01) decrease being detected at 48 h after initiating TGFb1 treatment. There was no signi®cant alteration in the amounts of cyclin D1 and cdk6 at all time points up to 48 h in response to TGFb1 (up to 40 ng/ml) ( Figure 1a ). Cyclin A polypeptide was expressed as a strong band around 57 kDa that was dramatically decreased by TGFb1 (5 ng/ml). The reduction started at 3 h and reached a maximum of 96% by 48 h (P50.001). TGFb1 also signi®cantly suppressed the expression of cdk2, with a maximal inhibition of 98% (P50.01), being detected by 48 h. The expression of cyclin E detected as a 55-kDa polypeptide was not aected by TGFb1 treatment at any time point up to 48 h, which is consistent with a previous report (Ko et al., 1993) . The downregulation of these cyclins and cdks by TGFb is not limited to this speci®c cell line since a similar inhibition of these G1 molecules has also been found in another human myeloid leukemia cell line, i.e. erythroid TF-1 cell line. This cell line showed profound growth inhibition in response to TGFb treatment (Drexler et al., 1998; Hu et al., 1999) . As seen from Figure 1b , at least, 50 ± 60% of cyclins D2, D3, and cdk2 (P50.05) were suppressed by TGFb1 by 24 and 48 h (the per cent inhibition was calculated based on image reading numbers as indicated in Figure 1 and`Materials and methods'). Cell cycle analysis by¯ow cytometry demonstrated that the majority of MV4-11 and TF-1 cells were arrested in G1 by 24 and 48 h after initiating TGFb1 treatment (Figure 1a,b) .
To determine whether the inhibition of cyclins D2, D3, and cdk2 is caused speci®cally by TGFb1, an antiTGFb1 neutralizing antibody was added to the cells for 1 h, followed by TGFb1 for another 24 h in the presence of the antibody. Preincubation of cells with anti-TGFb1 neutralizing monoclonal antibody at a concentration of 2 mg/ml blocked at least 75% of the inhibitory eect of TGFb1 on either of these molecules (Figure 1c ), whereas IgG, as a negative control had no eect on TGFb1-induced inhibition.
TGFb1 downregulates pRb-associated cdk2 and cdk4 and inhibits cyclin/cdk kinase activity Cyclin-cdk complexes are assumed to modify pRb by phosphorylation through direct contact, thereby promoting cell cycle progression toward DNA replication. To determine whether the downregulation of G1 cdks by TGFb1 aects the association of cdks with pRb, we next investigated pRb-cdk complex formation in proliferating cells and the cells treated with TGFb1 ( Figure 2a) . In an exponentially growing phase, MV4-11 cells (TGFb7) expressed both dephosphorylated (bottom band) and phosphorylated Rb protein (top band) at a molecular size of approximately 110 kDa. Addition of TGFb1 induced dephosphorylation of pRb, which is evidenced by marked reduction of phosphorylated pRb (top band). In proliferating cells (TGFb7), phosphorylated pRb was signi®cantly existed in pRb-cdk2, pRb-cdk4, pRb-cdk6 complexes, whereas in the cells treated with TGFb1, lower levels of phosphorylated pRb was detected in the complexes. In addition, the amounts of pRb associated with cdk2 and cdk4 in the cells treated with TGFb1 were also markedly decreased, whereas the amount of cdk6-associated pRb was not signi®cantly aected by TGFb1, with the exception of dephosphorylation of pRb.
Subsequently, in vitro kinase assays were performed to determine whether lower cyclin/cdk-pRb complexes actually led to a low kinase activity. Growing MV4-11 cells in the presence or absence of TGFb1 (5 ng/ml) for 48 h were collected and lysed. Cell lysates were then immunoprecipitated with dierent antibodies as described in Figure 2b . The kinase activities of the immunoprecipitates were measured by in vitro kinase assays, using GST-Rb or Histone H1 (for cyclin A) as a substrate in the presence of [g-32 P]ATP. As seen from Figure 2 , high levels of cdk2, cyclin E, and cyclin Adependent kinase activities were observed in proliferating cells, whereas the cyclin D2 and cyclin D3 dependent kinase activities were expressed to a lesser degree. Addition of TGFb1 dramatically inhibited Oncogene TGFb-mediated cell cycle control X Hu et al cdk2, cyclin A-, cyclin E-, cyclin D3-, and cyclin D2-dependent kinase activities by 78% (P50.01), 98% (P50.001), 77% (P50.01), 79% (P50.01), and 66% (P50.05), respectively. MV4-11 cells treated with TGFb1 also showed a low cdk4 kinase activity, which has been reported previously (Hu et al., 1999) . As negative controls, IgG immunoprecipitates either from proliferating MV4-11 cells or in the cells treated with TGFb1 lacked kinase activity.
TGFb accelerates D-type cyclin turnover and inhibits cdk2 synthesis
The data described above suggest that downregulation of G1 cyclins and cdks is a dominant event in TGFbinduced growth inhibition in human myeloid leukemia cells. The decrease in D-type cyclins and cdk2 could potentially be due to a decreased rate of synthesis or an accelerated rate of degradation. To clarify this question, MV4-11 cells were treated with or without TGFb1 for 24 ± 72 h and then were pulse-labeled with TGFb1 inhibits expression of cyclins D2, D3, and cdk4 but not cyclin D1 or cdk6. (a,b) Cells were incubated with or without TGFb1 (5 ng/ml) for the indicated times. Cells were harvested, washed, and lysed in lysis buer. An aliquot of lysates containing 50 mg of total proteins was separated by SDS ± PAGE followed by immunoblotting with antibodies against cyclin D1, cyclin D2, cyclin D3, cyclin A, cyclin E, cdk2, cdk4 and cdk6. The blots presented here are representative of four independent experiments from MV4-11 (a) and TF-1 (b) cells. Cell cycle analysis by¯ow cytometry was shown on the bottom of a and b, respectively. Expressed proteins were quantitated by image reading, using ImageQuant and per cent increase or decrease was calculated as described in`Materials and methods'. (c) Cells were pretreated with or without anti-TGFb1 neutralizing antibody or rabbit IgG for 1 h at 378C. TGFb1 (5 ng/ml) was then added to the cells and incubated for 24 h. Thereafter, the cells were collected and lysed in lysis buer. Cell lysates were prepared and tested for the expression of cyclin D2, cyclin D3, and cdk2 as described iǹ Materials and methods'. Proteins expressed were quantitated by image reading as described under`Materials and methods'. The per cent inhibition was then calculated. The values presented are from two independent experiments from MV4-11 cells proteins was accelerated in TGFb1-treated cells, which is chase time-dependent, with a maximal decrease of cyclin D2 and cyclin D3 being detected by 3 ± 4 h chase ( Figure 3b ). In contrast, inhibition of cdk2 was directly related to the time treated with TGFb1 in terms of the levels of labeled cdk2, with a maximal inhibition (95%, P50.001) being observed by 72 h after initiating TGFb1 treatment ( Figure 3a ). The cdk2 inhibition by TGFb1 is chase time-independent since as long as 4 h chase had no eect on the levels of cdk2. These data suggest that TGFb1-mediated growth inhibition is not by a single mechanism: downregulation of cyclins D2 and D3 is a result of degradation, whereas inhibition of cdk2 is due to a decrease of biosynthesis rate.
Differential effects of TGFb1 on p27
kip1 and p27 kip1 complexes Since p27 kip1 has been reported to bind to cyclin/cdk complex and prevent the complex phosphorylation and activation Reynisdottir et al., 1995; Kato et al., 1994; Sherr and Roberts, 1995) . Cell cycle arrest by TGFb1 described above could also result from upregulation of p27 kip1 . To assess this possibility, the expression of cip/kip family in MV4-11 cells before and after TGFb1 treatment was examined by Western blotting. As shown in Figure 4 , small amounts of p27 kip1 protein were present in untreated MV4-11 cells. After addition of TGFb1, the levels of p27 kip1 were dramatically increased. This eect was rapid and was detected as early as 3 h upon TGFb1 treatment. By 24 h, the expression of p27 kip1 was increased by *10-fold and reached a maximum of *20-fold by 48 h. TGFb1 did not alter the levels of p15 INK4B during the time tested. By using several monoclonal and polyclonal antibodies we failed to show the expression of p21
Cip1 in this cell line (data not shown).
Next, we asked whether p27 kip1 plays any inhibitory role on cyclin/cdk activity and accounts for TGFbmediated growth inhibition. Since little information is available concerning p27 kip1 -cyclin/cdk complexes in human hematopoietic cells, we initially thought that up-regulated p27 kip1 would play a negative role through a direct contact with cyclins or cdks in response to TGFb1. Therefore, the association of p27 kip1 with each cyclin and cdk was investigated. Cell lysates made from MV4-11 cells treated with or without TGFb1 were immunoprecipitated with anti-p27 kip1 , -cyclin E, -cdk2, -cdk4, -cdk6, or -cyclin A antibody. The immunoprecipitates were resolved on SDS ± PAGE, transferred to nitrocellulose membranes, and blotted with anti-cdk, -cyclin or -p27 kip1 antibody as indicated in Figure 4 . Surprisingly, proliferating MV4-11 cells (TGFb1-) in culture clearly expressed p27 kip1 -associated cdk2, cdk4, cdk6, cyclin D1, cyclin D2, and cyclin D3. In contrast, p27 kip1 -associated cdk2, cyclin D3, and cdk4 were signi®cantly downregulated in the cells treated with TGFb1, each with more than 80% reduction being observed, measured by ImageQuant (see Materials and methods). TGFb1 also signi®cantly decreased p27 kip1 -associated cyclin D2 by *60% by 48 h. To con®rm our results, we used cdk2, cdk4, cdk6, cyclin D1, cyclin D2, or cyclin D3 antibody to immunoprecipitate corresponding proteins from lysates of MV4-11 cells treated with or without TGFb1, then probed with p27 kip1 antibody. Similar low levels of cdk2-, cyclin D3-, and cdk4-associated p27 kip1 were detected in the cells treated with TGFb1 (data not shown). TGFb1 slightly upregulated p27 kip1 -associated cdk6. Since IgG interferes with detection of p27 kip1 -associated cyclin E and cyclin A (both IgG and cyclin A have about the same molecular size), we thus examined the expression of cyclin E-and cyclin A-associated p27 kip1 (i.e. IP: cyclin E or cyclin A; WB: p27 kip1 ) in the presence or absence of TGFb1. Our results showed that proliferating cells Figure 2 TGFb1 downregulates pRb association with cdk2, cdk4, and inhibits cdk and cyclin-dependent kinase activities. MV4-11 cells were cultured in the absence (7) or presence (+) of 5 ng/ml TGFb1 for 48 h. The cells were collected and lysed in lysis buer. An aliquot of lysates containing 500 mg of total proteins was immunoprecipitated with an antibody against pRb, cdk2, cdk4, or cdk 6 for 2 h or overnight at 48C. Subsequently, protein G-agarose beads were added to these immunoprecipitates and incubated for 2 h. Immune complexes were separated by 8% SDS ± PAGE, and the expression of the complex-associated pRb was detected by Western blotting using anti-pRb antibody (a). An aliquot of lysates containing 200 mg of total proteins from TGFb1-treated or untreated cells was immunoprecipitated at the same condition as described above. After two washes in lysis buer and two washes in kinase buer, the kinase reaction was carried out in kinase buer at 308C for 30 min, using GST-Rb or histone H1 as a substrate. After separation on SDS ± PAGE, the kinase reaction was detected by exposing the gel to X-ray ®lm, as described in`Materials and methods' (b). The blots were quantitated by image reading (see`Materials and methods') and blot values presented here are representative of two (a) or three (b) independent experiments Oncogene TGFb-mediated cell cycle control X Hu et al (TGFb17) expressed cyclin E and cyclin A-associated p27 kip1 . Addition of TGFb1 signi®cantly upregulated cyclin E-associated p27 kip1 by 84% and downregulated cyclin A-associated p27 kip1 by 90% by 48 h. TGFb1 had no eect on the levels of p27 kip1 -associated cyclin D1. Since the above experiments used the whole cell lysates, it was still not clear whether TGFb1 aected cdk2-p27 kip1 complexes in the cell nucleus. To address this question, cytosol and nuclear extracts were prepared from proliferating and TGFb1 treated cells as described in the`Materials and methods'. As shown in Figure 5 , p27 kip1 , cdk2 (Figure 5a ), and p27 kip1 /cdk2 complexes (Figure 5b ) are expressed in both cytosol and nucleus in proliferating cells (TGFb7), whereas most of cyclin E are existed in the nucleus. Addition of TGFb1 caused a marked decrease of cdk2 and p27 kip1 / Figure 4 Dierential eects of TGFb1 on p27 kip1 and p27 kip1 complexes. Cells were incubated with or without TGFb1 (5 ng/ml) for the times indicated in the ®gure. Cells were harvested, washed, and lysed in lysis buer. An aliquot of each lysate was separated by SDS ± PAGE, followed by immunoblotting with anti-p27 kip1 , or -p15 INK4B antibody. The blots presented here are representative of three independent experiments (a). MV4-11 cells were cultured in the absence (7) or presence (+) of 5 ng/ml TGFb1 for 24 and 48 h. The cells were collected and lysed in lysis buer. Equal amounts (500 mg of total proteins) of lysates were immunoprecipitated with anti-p27 kip1 (b), cyclin E (c), or cyclin A (c) antibody, respectively. Immune complexes were separated by 12% SDS ± PAGE, and the expression of the complex-associated proteins was detected by Western blotting with the antibodies indicated in the ®gure. The blots presented here are representative of three independent experiments and the blots were quantitated by image reading (seè Materials and methods') -cyclin E complexes, with a ®vefold increase being detected in both the cytosol and nucleus. p27 kip1 has opposing effects on cdk2 and cyclin E activity
The results described above clearly demonstrated that downregulation of G1 cyclins and cdks is a dominant event in TGFb1-mediated growth inhibition of MV4-11 cells. The signi®cant expression of p27 kip1 -cdk4 complexes suggests that p27 kip1 is required for cdk4 kinase activity, which is consistent with recent ®ndings (Cheng et al., 1999) . In addition, our data also demonstrated that p27 kip1 is dominantly associated with cdk2 in proliferating but not TGFb1-treated MV4-11 cells, suggesting the possibility that p27 kip1 may be required for cdk2 activity. To test this hypothesis, we immunodepleted p27 kip1 from lysates extracted from proliferating cells and cells arrested in G1 by TGFb1 and then measured cdk2 kinase activity using GST-Rb as a substrate. Proliferating MV4-11 cells expressed very strong cdk2 kinase activity ( Figure 6, lane 1) . Surprisingly, p27 kip1 immunodepletion caused a marked decrease of cdk2 kinase activity by 77% (lane 3), whereas depleted p27 kip1 -immunoprecipitates exhibited some cdk2 kinase activity (*5% of total cdk2 kinase activity) (lane 2). The cdk2 kinase activity in the cells treated with TGFb1 was only approximately 19% of the kinase activity in the cells without TGFb1 treatment (lane 4). Again, p27 kip1 depletion caused the downregulation of cdk2 kinase activity by more than 75% (lane 6). Depleted p27 kip1 showed a little cdk2 kinase activity (lane 5). These data suggest that at least some cdk2 kinase activity is associated with p27 kip1 . Since the p27 kip1 associated cdk2 kinase activity in proliferating MV4-11 cells is much less than p27 kip1 -depleted cdk2 kinase activity, it suggests that p27 kip1 may acts as an adapter for cdk2 activity. Proliferating MV4-11 cells also expressed a strong cyclin Edependent kinase activity (lane 1). Depletion of p27 kip1 slightly decreased cyclin E-dependent Rb kinase activity (lane 3) and p27 kip1 immunoprecipitates lacked signi®cant the kinase activity (lane 2). In contrast, TGFb1-treated MV4-11 cells expressed very limited cyclin E kinase activity (lane 4), depletion of p27 kip1 greatly increased cyclin E-dependent kinase activity by *85% (lane 6). Again, p27 kip1 immunoprecipitates from TGFb1 treated cells had no signi®cantly associated cyclin E kinase activity (lane 5).
In an attempt to con®rm the results from the approaches using`p27 kip1 depletion', we constructed a full-length antisense p27 kip1 cDNA (see`Materials and Figure 5 TGFb1 down-regulates p27 kip1 -cdk2 complexes in both the cytosol and nucleus. MV4-11 cells treated with or without TGFb1 for 48 h, after which nuclear and cytosol extracts were prepared and protein concentrations were measured. (a) Aliquots of lysates were subjected to Western blotting for analysis of expression of p27 kip1 , cdk2, or cyclin E. (b) lysates containing equal amounts of total proteins were immunoprecipitated with anti-p27 kip1 or anti-cyclin E antibody coated with protein G agarose, and the association of p27 kip1 with cdk2 or cyclin E was detected by Western blotting with antibodies against p27 kip1 and cdk2, as described in`Materials and methods'. The blots presented here are representative of three independent experiments Figure 6 p27 kip1 is required for cdk2 kinase activity. MV4-11 cells treated with (lanes 4 ± 6) or without TGFb1 (lanes 1 ± 3) for 48 h were harvested by centrifugation and lysed in lysis buer. Lysates containing 200 mg of total proteins were either immunoprecipitated with cdk2 or cyclin E with agitation at 48C overnight. Subsequently, 30 ml of protein A Sepharose beads were added to the lysates and incubation continued for another 2 h at the same conditions. Cdk2 or cyclin E immune complexes were washed twice with 16lysis buer and twice with 26kinase buer before the kinase assay using GST-Rb as a substrate (this is total cdk2 or cyclin E-dependent kinase activity). In parallel experiments, lysates containing the same amount of total proteins were ®rst immunoprecipitated with anti-p27 kip1 antibody at the same conditions described above, after which the lysates were centrifuged and the supernatants (p27 kip1 free) were transferred to a fresh tube, while the pellets (p27 kip1 immunoprecipitates) were resuspended in 200 ml of lysis buer. Both p27 kip1 pellets and p27 kip1 free supernatants were immunoprecipitated again with cdk2 or cyclin E antibody. The p27 kip1 -associated cdk2 or cyclin E kinase and p27 kip1 -free cdk2 or cyclin E kinase were then measured, as described in`Materials and methods'. 1 and 4: total cdk2 or cyclin E kinase activity, 2 and 5: p27 kip1 -associated cdk2 or cyclin E-dependent kinase activity, 3 and 6: p27 kip1 -free cdk2 or cyclin E-dependent kinase activity. The blots presented here are representative of three independent experiments. PCTR: positive control from GM-CSF treated TF-1 cell extracts Oncogene TGFb-mediated cell cycle control X Hu et al methods'), and transiently expressed in MV4-11 cells. As controls, transfection with sense p27 kip1 cDNAs and empty plasmid (PCDM8) were also performed. After 48 h, the cells were collected and kinase activity was determined. The transfection eciency was determined by measuring the expression of p27 kip1 protein. As shown in Figure 7a , the control cells (pCDM8) expressed p27 kip1 , whereas the cells with anti-sense p27 kip1 plasmid (15 mg) had a much low abundance of p27 kip1 with an approximately 80% decrease in p27 kip1 levels being observed. Sense-p27 kip1 cDNA had no signi®cant eect on the expression of p27 kip1 . Anti-sense p27 kip1 cDNA had no eect on the expression of p15 The anti-sense construct reduced the expression of endogenous p27 in a dose-dependent manner. As low as 1 mg of anti-sense p27 cDNA decreased p27 levels by 15%, with a maximal inhibition (80%) being obtained with 15 mg of anti-sense plasmid ( Figure  7b ). With this degree of inhibition of p27 kip1 , we then investigated whether anti-sense p27 kip1 aected cdk2 and cyclin E-dependent kinase activity and blocked the inhibitory eect of TGFb1. MV4-11 cells, with or without transfection for 48 h, followed by TGFb1 treatment for another 24 h, were collected, lysed, and the cdk2 and cyclin E-dependent kinase activities were measured by in vitro kinase assay, using GST-Rb as a substrate. Control cells transfected with empty vector (PCDM8) showed very strong cdk2 (Figure 7c , lane 1) and cyclin E kinase activities (lane 5), whereas transfection with anti-sense-p27 kip1 downregulated cdk2 kinase activity by 60% (lane 2), with no signi®cant eect on cyclin E-dependent kinase activity (lane 6). Addition of TGFb1 to the cells transfected with pCDM8 markedly inhibited both cdk2 and cyclin E-dependent kinase activities by 75% (lane 3) and 70% (lane 7), respectively. Cells transfected with anti-sense p27 kip1 followed by TGFb1 treatment showed the lowest cdk2 kinase activity (lane 4). However, there is ), or empty plasmid (PCDM8) were incubated at 378C for 48 h followed by addition of TGFb1 for another 24 h as indicated iǹ Materials and methods'. Subsequently, the cells were collected, lysed and protein concentration was measured. An aliquot of lysates containing the same concentration of total proteins was loaded to SDS ± PAGE for Western blotting for the expression of p27 kip1 and p15 INK4B (AS: Antisense, S: Sense). (b) MV4-11 cells transfected with or without anti-sense p27 kip1 plasmid at doses of 0.5 ± 20 mg for 48 h were collected and lysed in lysis buer. The expression of p27 kip1 was analysed by Western blotting probed with anti-p27 kip1 antibody. The quantitation of individual bands after subtraction of background using a scanning densitometer was calculated as per cent expression. The expression of p27 kip1 in control cells without anti-sense p27 kip1 plasmid (0 mg) is set as 100%. (c) Aliquots of lysates were immunoprecipitated with anticdk2 or -cyclin E antibody, after which cdk2 and cyclin Edependent kinase activity were performed, using GST-Rb as a substrate. The phosphorylation of GST-Rb induced by cdk2 and cyclin E is shown in the two panels under numbers 1 ± 8. The relative kinase activity is calculated from quantitation of individual bands after subtraction of background using a scanning densitometer. 1 and 5: empty plasmid (pCDM8); 2 and 6: Anti-sense p27 kip1 ; 3 and 7: pCDM8+TGFb1; 4 and 8: anti-sense p27 kip1 +TGFb1. The blots and values presented here are representative of two independent experiments. PCTR: positive control from GM-CSF treated TF-1 cell extracts no signi®cant dierence on cyclin E-dependent kinase activity between pCDM8 alone (lane 7) and anti-sense p27 kip1 (lane 8) transfected cells in the presence of TGFb1 (Figure 7c ).
Discussion
In this study, we presented evidence that TGFbmediated growth inhibition of human MV4-11 cells is accomplished through multiple pathways (Figures 1  and 3) . Previous studies have demonstrated that the inhibitory role of TGFb is the result of retaining cells in G1 phase and blocking the G1/S transition (Sherr, 1994) , which is linked to the inhibition of cyclin E-cdk2 complex assembly (Ko et al., 1993) . Subsequently, TGFb1 has been shown to inhibit synthesis of cdk4, which normally occurs at about the time of the R-point during G1 phase and works upstream of cdk2 (Eween et al., 1993) . It is generally agreed that in epithelial cells the quantities of D-type cyclins and cdk2 are not aected by TGFb1 (Fautsch et al., 1995; Geng and Weinberg, 1993) . Therefore, the major mechanism of TGFb action appears to be to negatively regulate G1 molecules through the changes of intrinsic properties of the cdk2 kinase, blocking G1 progression and G1-S transition. In theory, reduction of cdk4 protein alone may not be sucient to induce growth inhibition, since there are several cdks in mammalian cells, and D-type cyclins may bind to other cdks, such as cdk6, when cdk4 is inhibited. In this study, we have detected that TGFb1 suppressed not only cdk4, but also its regulating subunits cyclin D2 and cyclin D3 ( Figure  1 ). D-type cyclins are believed to play a role in promoting G1 progression and exit (Matsushime et al., 1991; Lew et al., 1991; Xiong et al., 1991; Ando et al., 1993) . The importance of cyclin D2 and cyclin D3 in proliferation and dierentiation of mammalian cells has been reported (Ando et al., 1993; Kato and Sherr, 1993) . Since cyclins D2 and D3-dependent kinase activites in MV4-11 cells are markedly suppressed as a result of downregulation of these two proteins by TGFb1, the results suggest that the downregulation of these two D-type cyclins might contribute to TGFbinduced inhibition of G1-S transition and cell proliferation. Cdk2 has an essential G1 to S progression function (Sherr, 1993) . Cdk2 is activated by binding to cyclins E and A and is inactivated by phosphorylation of tyrosine-15 or association with proteins designated cdk inhibitors (Sherr, 1993 (Sherr, , 1994 Hunter, 1995) . In epithelial Mv1Lu cells, TGFb1 had no eect on the synthesis of cdk2 and cyclin E but suppressed cdk2 kinase activity, which is believed to be a result of interfering with the assembly of cdk2-cyclin E complexes (Ando et al., 1993) . In human myeloid leukemia MV4-11 and TF-1 cells, although cyclin E remains at normal levels in TGFb1-treated cells, both cdk2 and cyclin A were signi®cantly downregulated by TGFb1 (Figure 1) . As a result of cdk2 reduction, formation of cdk2-p27 kip1 and cdk2-cyclin E complexes was decreased during the G1 phase of the cell. Therefore, the lack of sucient cdk2 protein may contribute, at least in part, to the downregulation of cdk2 activity and the mechanism underlying TGFb1-blockade of G1/S transition. Thus, it appears that TGFb1-mediated growth inhibition in MV4-11 and Mv1Lu cells is regulated by distinct mechanisms. By using metabolic labeling, we demonstrated that downregulation of cyclins D3 and cyclins d2 by TGFb1 was a result of degradation of the molecules, whereas inhibition of cdk2 is due to a decrease of biosynthesis rate of cdk2 in response to TGFb1 (Figure 3) . These results suggest that down-regulation of the multiple G1 cyclin and cdk is a dominant event in TGFb1-mediated growth inhibition of MV4-11 and TF-1 myeloid leukemia cell lines, which is regulated by distinct mechanisms. p27 kip1 was initially thought to interfere with the activities of cyclin D-, E-, and A-dependent kinases. Overexpression of p27 kip1 in cultured cells arrests the cell cycle. The crystal structure of p27 kip1 bound to cyclin-cdk2 reveals that a p27 kip1 fragment inserts itself within the cdk2 catalytic site, blocking ATP access (Russo et al., 1996) . These data lead to a simple model in which anti-proliferative stimuli up-regulate p27 kip1 , followed by inhibition of cyclinD-cdk4, cyclinE-cdk2, cyclinA-cdk2 activities, and by G1 arrest. However, the structure of the equivalent complex with full-length p27 kip1 is not known, and it remains a possibility that such a complex may support kinase activity. More recent work has revealed that the Cip/Kip proteins act as positive regulators of cyclin D-dependent kinases (Cheng et al., 1999; LaBaer et al., 1997) . The ®nding reported here that p27 kip1 is associated with cdk2 in S phase and has dierential eects on cdk2 and cyclin E (Figures 4, 6 and 7) adds new information about how the G1/S transition of the mammalian cell cycle may be governed. By using several independent approaches we have demonstrated that cdk2 and cyclin E are regulated in two dierent ways by TGFb1. TGFb1 had no eect on the amount of cyclin E, which is consistent with previous reports in epithelial cells (Hunter, 1995) , but upregulated cyclin E-associated p27 kip1 . In contrast, TGFb1 downregulated the expression of cdk2, resulting in a low level of cdk2-associated p27 kip1 . It has been reported that p15 INK4B is localized mostly in cytoplasm, whereas p27 kip1 is in nuclear (Reynisdottir and Massgue, 1997) . However, recent studies have demonstrated that ®broblasts and some tumor cells contain substantial amounts of cytoplasmic p27 kip1 (Wang et al., 1999; Singh et al., 1998; Orend et al., 1998) . In MV4-11 and two other myeloid leukemia cell lines (TF-1 and Mo7e), we found that the most of total p27 kip1 is located in the cytoplasm in proliferating MV4-11 cells. TGFb1 induced a marked increase of p27 kip1 in both the cytoplasm and nucleus ( Figure 5 ), but signi®cantly downregulated p27 kip1 -cdk2 complexes. These results are against the notion that p27 kip1 is a negative regulator of cdk2 kinase in vivo, at least in MV4-11 and TF-1 leukemia cells. By carrying out p27 kip1 immunodepletion and transfection experiments, we showed here that at least some cdk2 kinase activity Oncogene TGFb-mediated cell cycle control X Hu et al is associated with p27 kip1 in MV4-11 cells ( Figure 6 ). However, the p27 kip1 -associated cdk2 kinase activity in proliferating MV4-11 cells is much less than the p27 kip1 -depleted cdk2 kinase activity, suggesting that p27 kip1 may act as an adapter for cdk2 activity. Additional support for this possibility is the observation that cells transfected with anti-sense p27 kip1 cDNA but not empty plasmid, downregulated cdk2 kinase activity by about 60%. Although p27 kip1 also may act as an adapter of cyclin E activity, as suggested by expression of cyclin E-p27 kip1 complexes in proliferating MV4-11 cells (Figure 4) , p27 kip1 mainly acts as an inhibitor of cyclin E activity in response to TGFb1. This is indicated by the fact that TGFb1 upregulated cyclin E-associated p27 kip1 ( Figure 4) and was accompanied by the inhibition of cyclin E-dependent kinase activity ( Figure  2) . Moreover, p27 kip1 immunodepletion dramatically upregulated cyclin E-dependent kinase activity in TGFb1 treated cells (Figure 6 ). Thus, it appears that the eect of p27 kip1 on cyclin E-dependent kinase activity is dosedependent, with only high concentrations of p27 kip1 being inhibitory to cyclin E activity. This may explain the observation that immunodepletion of p27 kip1 or anti-sense p27 kip1 cDNA did not signi®cantly increase cyclin E-dependent kinase activity in proliferating MV4-11 cells. These data appear to be similar to the previous reports regarding p21 cip1 function. It has been reported that p21 cip1 , at low concentration, promotes the assembly of active kinase complexes, whereas a high concentration of p21 cip1 causes the opposite eect (Matsushime et al., 1992) . In cells transfected with antisense p27 kip1 cDNA, the downregulation of cyclin Edependent kinase by TGFb1 is most likely caused by inhibition of cdk2 synthesis or cdk2-cyclin E assembly, since TGFb1 is incapable to upregulate p27 kip1 ( Figure  7 ). Our data are consistent with previous ®ndings, in which cell cycle arrest mediated by TGFb remained intact in p277/7 cells (Nakayama et al., 1996) . Taken together, we interpret our results to suggest that in proliferating cells p27 kip1 is associated with cdk2 and cdk4 as an adapter. TGFb1 downregulates cdk2, cdk4, and D-type cyclins, which leaves p27 kip1 free to bind and saturate cyclin E, inhibiting cyclin E-cdk2 assembly, rendering cyclin E-dependent kinase inactive. By using these two dierent regulatory mechanisms, TGFb1 magni®es its cell cycle inhibitory eciency. agitation at 48C. About 30 ml of protein A or protein Gagarose beads were then added to the lysates and the incubation continued for another 1 h at the same condition. Immune complexes were washed three times with lysis buer and resuspended in 26SDS sample buer (125 mM Tris-HCl, pH 6.8, 4% SDS, 20% glycerol, 100 mM DTT, 0.2% bromophenol blue). Lysates in the sample buer were heated at 1008C for 4 min before being applied to 6 ± 15% SDS ± PAGE. The proteins in the gel were electrophoretically transferred to a nitrocellulose membrane (Amersham, Arlington Heights, IL, USA) and blotted in blocking buer (5% dry milk in 16TBST ± 20 mM Tris, 137 mM NaCl, pH 7.6, 0.1% Tween-20) for 1 h at room temperature. Subsequently, the membrane was immunoblotted with an appropriate primary antibody for 1 h at room temperature or overnight at 48C. Unbound antibody was removed by washing the membrane in 16TBST buer for three times, each 5 min. The membrane was then incubated with an HRPconjugated secondary antibody for 1 h at room temperature followed by addition of 16TBST buer as described above. Antibody reaction was detected by a chemiluminescence reaction (New England BioLabs, Beverly, MA, USA). For Western blotting, lysates containing 30 ± 50 mg of total proteins were loaded to SDS ± PAGE followed by the procedure described above.
Measurement of biosynthesis and turnover rate of cyclin and cdk
Cells treated with or without TGFb1 for 24 ± 72 h. One hour prior to harvesting, culture medium will be replaced with methionine-free medium supplemented with 10% fetal bovine serum and 300 mCi/ml of [ 35 S]methionine. Cell lysates will be prepared in lysis buer. An equal amount of protein from each sample will be immunoprecipitated with anti-cyclins D3, D2, or cdk2 antibody with protein-G agarose, resolved by SDS ± PAGE, and visualized by autoradiography. For pulsechase experiment, cells treated with or without TGFb1 for 48 h, after which culture medium was removed by centrifugation and cells were pulse-labeled with [ 35 S]methionine for 1 h at 378C. After removal of labeling medium, cells were incubated in the presence of an excess of nonradioactive methionine for various additional times. Immunoprecipitated cyclins D3, D2, and cdk2 were resolved by SDS ± PAGE and visualized by autoradiography.
In vitro kinase assay
Cyclin or cdk kinase activity was measured as described previously (Toyoshima and Hunter, 1994) . Brie¯y, preclari®ed lysates (200 mg of total protein) extracted from cells treated with or without TGFb1 were immunoprecipitated for 2 h at 48C with anti-cdk or -cyclin antibody followed by addition of protein A Sepharose beads for 1 h. The lysates were collected by centrifugation and washed. After three washes in lysis buer (20 mM Tris, 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1% Triton, 2.5 mM sodium pyrophosphate, 1 mM b-glycerophosphate, 1 mM PMSF, 1 mM Sodium orthovanadate, 1 mg/ml Leupeptin) and two washes in kinase buer (50 mM HEPES, pH 7.5, 10 mM MgCl 2 , 10 mM DTT), the kinase reaction was carried out in a total volume of 10 ml, which included 5 ml of 26kinase buer containing 10 mCi [g-32 p]ATP and 2 mg of histone H1 or GST-Rb at 308C for 30 min. The reaction was stopped by adding 10 ml of 26sample buer and boiling for 4 min before separation by SDS ± PAGE. The gel was then dried and exposed to a ®lm (Kodak XAR-5), and speci®c bands were quanti®ed by densitometry.
Construction of anti-sense p27 kip1 cDNA and transient transfection Total cellular RNA was isolated from 5610 6 cells from human peripheral blood mononuclear cells and from MV4-11 cell line by the acid-guanidinuum thiocyanate-phenol-chloroform method using Trizol reagent following the manufacturer's procedure (Life Technology, Gaithersburg, MD, USA). RNA was then reverse transcribed (RT) using random hexamers, and full-length cDNA clones (antisense) encoding p27 kip1 (597 bp) were isolated by PCR using HindIII (3' site) and XbaI (5' site)-tagged oligonucleotides (28 mer). The PCR product was inserted into HindIII and XbaI sites of expression plasmid, PCDM8. The sense cDNA of p27 kip1 was generated by PCR using HindIII-tagged 5'-oligonucleotide (CTGCAAGCTTATGTCAAACGTGCGAGTG) and XbaI-tagged 3'-oligonucleotide (GCGTCTAGATTACGTTT-GACGTCTTCTG).
The DEAE-Dextran technique was used to introduce p27 kip1 genes into MV4-11 cells. MV4-11 cells in log phase were washed once with Tris-HCl (pH 7.5), and resuspended in Tris-HCl at a concentration of 2610 6 /ml. A DEAEDextran-DNA mixture containing 0.5 ± 20 mg of plasmid DNA was prepared following the manufacturer's instructions, and 200 ml of the mixture was added, drop by drop, to the 1 ml of cell suspension described above. The cells were then incubated for 15 min at 378C and rocked every 5 min to spread the solution evenly across the cells. After the reaction, the cells were collected by centrifugation, washed once in Tris-HCl (pH 7.5), and resuspended in complete culture medium. After 1 ± 3 days (dependent on the degree of p27 kip1 inhibition), cells were collected and lysed in lysis buer. Aliquots of lysates were analysed by Western blotting for the expression of p27 kip1 and p15 INK4B or immunoprecipitated with an antibody for in vitro kinase assays.
Statistical analysis
Quantities of proteins detected by in vitro kinase assay, Western blot, and immunoprecipitation were numbered by image reading, using ImageQuant (Molecular Dynamics, Sunnyvale, CA, USA). The numbers produced were proportional to the degree of protein expression. Per cent of decrease or increase in protein levels were then calculated. Cell cycle data were expressed as the mean+s.d. (standard deviation), which was obtained from two to four separate experiments. The statistical signi®cance of dierences between group means or protein quantities was determined using the Student's t-test.
